Case Report
Clinical Misdiagnosis of COVID-19 Infection with Confusing Clinical Course
Table 1
Laboratory findings of the patient during admission.
| Parameter | Baseline | Day 1 | Day 2 | Day 3 | Day 4 | Day 5 | Day 6 |
| Uric acid (3–5.5 mg/dl) | 2.8 | | Cholesterol (130–200 mg/dl) | 467 | | 390 | | 456 | TG (40–160 U/L) | 735 | | 331 | | 340 | | 296 | AST (10–40 U/L) | 103 | 31 | 143 | 62 | 83 | 45 | 31 | ALT (10–40 U/L) | 121 | 49 | 91 | 45 | 38 | | 21 | Bili total (1–1.2 mg/dl) | 7 | | 2.4 | Bili direct (0.1–0.4 mg/dl) | 0.6 | | 0.5 | LDH (5–850 IU/L) | 770 | | 729 | Albumin (3.5–5.2 gr/dl) | 3.8 | 2.9 | 2.5 | 3.3 | 3.1 | 4 | 3.5 | Total protein (5.7–8 gr/dl) | 4.6 | | 4.5 | | 5.3 | | 5.8 | CRP (<6 mg/L) | 12 | | 12 | | 11 | ESR (<15 mm/hours) | 28 | | Procalcitonin (<0.05 ng/ml) | 1.6 | | 0.1 | CPK (24–195 U/L) | 17 | | Fibrinogen (150–350 mg/dl) | 245 | | 180 | | 147 | WBC ((4–10) × 103/UL) | 3.41 | | 2.17 | 1.74 | | 2.44 | 2.13 | PMN ((2–7) × 103/UL) | 16.6 | | 14.7 | 26 | | 6.6 | 3.8 | Lymph ((0.8–4) × 103/UL) | 72 | | 70 | 68 | | 61 | 69.6 | RBC ((3.5–5.5) × 103/UL) | 2.8 | 1.94 | 2.84 | 2.77 | 2.33 | 2.96 | 2.43 | Hb (11–16 gr/dl) | 7.6 | | 5.2 | 7.8 | | 8 | 6.6 | Ferritin (30–220 ng/ml) | 7720 | 6770 | 3480 | 24320 | 18800 | 27760 | 19360 | Plt ((150–450) × 103/UL) | 37 | | 32 | 23 | | 13 | 20 | PT (11–13.8 second) | 14 | | 12.5 | PTT (11–13.8 second) | 33 | | 36 | INR (2, 3) | 1.2 | | 1 | CD4 (31–64%) | 52 | | 50 | | 12 | CD8 (8–41%) | 21 | | 28 | | 79 | C3 (81–170 mg/dl) | 149 | | C4 (9.2–34 mg/dl) | 63 | | CH30 (70–150) | 140 | | Antitetanus (<0.1 IU/ml) | 0.24 | | Antidiphtheria (<0.1 IU/ml) | 0.07 | | NBT (90–100) | 100% | | DAT | 1/3200 | | SARS-CoV-2 (COVID-19) IgG (<0.9) | 0.5 | | SARS-CoV-2 (COVID-19) IgM (<0.9) | 0.1 | |
|
|